REFINE | Phase II multi-arm basket protocol testing reduced intensity immunotherapy across different cancers |
RAMPART | Phase III MAMS platform trial of adjuvant therapy in resected intermediate/high risk renal cell cancer |
Add-Aspirin | Phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours |
STAMPEDE | Phase III MAMS RCT evaluating Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy |
For the API
|
For the PI
For Study Team/CTU
For the Patient
|
The MRC CTU at UCL will be running a monthly webinar series on the last Tuesday of every month (6-7pm via TEAMS) for all APIs affiliated with a trial at the MRC CTU at UCL.
There will be a range of expert speakers including statisticians, health economists, and experienced investigators.
The timetable for the next webinar series is below:
Tuesday 31st January |
Understanding statistics: Hazard ratios, sample size, power calculations |
Matthew Nankivell Senior Statistician MRC CTU at UCL |
Tuesday 28th February |
How to be a good Principal Investigator |
Duncan Gilbert Clinical Lecturer MRC CTU at UCL and Consultant Clinical Oncology at Brighton and Sussex University Hospital |
Previous webinar recordings are available in the links below:
Go to the NIHR Associate PI Scheme Website: www.NIHR.ac.uk/AssociatePIScheme.
To register a study, complete the Associate PI Scheme Study Registration Form.
To register to be an Associate PI, complete the Associate PI Scheme Applicant Registration Form.